Chemoinformaics analysis of 14ALPHA-HYDROXYIXOCARPANOLIDE
| Molecular Weight | 488.621 | nRot | 2 |
| Heavy Atom Molecular Weight | 448.301 | nRig | 30 |
| Exact Molecular Weight | 488.277 | nRing | 6 |
| Solubility: LogS | -4.138 | nHRing | 2 |
| Solubility: LogP | 2.454 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 75 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 7 | APOL | 79.0457 |
| nHD | 3 | BPOL | 45.3363 |
| QED | 0.311 |
| Synth | 5.873 |
| Natural Product Likeliness | 3.125 |
| NR-PPAR-gamma | 0.675 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.65 |
| Pgp-sub | 0.002 |
| HIA | 0.046 |
| CACO-2 | -4.888 |
| MDCK | 0.00002 |
| BBB | 0.994 |
| PPB | 0.639973 |
| VDSS | 1.125 |
| FU | 0.37133 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.617 |
| CYP2c19-inh | 0.013 |
| CYP2c19-sub | 0.789 |
| CYP2c9-inh | 0.017 |
| CYP2c9-sub | 0.072 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.137 |
| CYP3a4-inh | 0.448 |
| CYP3a4-sub | 0.784 |
| CL | 10.005 |
| T12 | 0.05 |
| hERG | 0.019 |
| Ames | 0.019 |
| ROA | 0.984 |
| SkinSen | 0.013 |
| Carcinogencity | 0.43 |
| EI | 0.008 |
| Respiratory | 0.808 |
| NR-Aromatase | 0.921 |
| Antiviral | Yes |
| Prediction | 0.718387 |